Literature DB >> 8012988

Autocrine factor enhancing the secretion of M(r) 95,000 gelatinase (matrix metalloproteinase 9) in serum-free medium conditioned with murine metastatic colon carcinoma cells.

S Hyuga1, Y Nishikawa, K Sakata, H Tanaka, S Yamagata, K Sugita, S Saga, M Matsuyama, S Shimizu.   

Abstract

We previously reported that murine tumor cells with a high spontaneous metastatic potential to the lung secrete higher amounts of M(r) 95,000 gelatinase (matrix metalloproteinase 9, MMP9) than do poorly metastatic cells. The present study, conducted to clarify the mechanisms underlying the increase in MMP9, revealed an autocrine factor that enhances the secretion of M(r) 95,000 gelatinase (MMP9). The secretion of MMP9 by highly metastatic colon carcinoma LuM1 cells, detected by zymography, was augmented 10-fold when cultured in medium supplemented with serum-free medium conditioned with LuM1 cells. Because the secretion of M(r) 60,000 gelatinase (MMP2), as well as total protein, by the same cells was not affected under these conditions, the augmentation appears specific for MMP9. The steady-state level of MMP9 mRNA was elevated in LuM1 cells cultured in the presence of the supernatant. The amount of the factor in the culture medium increased with time in culture, indicating that it was produced by the LuM1 cells. It was found to be heat stable but sensitive to trypsin digestion. Conditioned medium from poorly metastatic NM11 cells did not stimulate the secretion of gelatinases by NM11 cells, suggesting that autocrine stimulation of MMP9 secretion is a characteristic of metastatic cells. This factor could account for the augmented secretion of MMP9 by murine tumor cells with spontaneous metastatic potential to the lung.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012988

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro.

Authors:  T Okada; J Li; M Kodaka; H Okuno
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

2.  Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens.

Authors:  Y Kobayashi
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Matrix Metalloproteinase-9-Responsive Nanogels for Proximal Surface Conversion and Activated Cellular Uptake.

Authors:  Mallory R Gordon; Bo Zhao; Francesca Anson; Ann Fernandez; Khushboo Singh; Celia Homyak; Mine Canakci; Richard W Vachet; S Thayumanavan
Journal:  Biomacromolecules       Date:  2018-02-08       Impact factor: 6.988

4.  Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.

Authors:  A H Borchers; L A Sanders; G T Bowden
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences.

Authors:  C C Cate; D R Belloni; M Marin-Padilla
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

6.  Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes.

Authors:  C J Swallow; M P Murray; J G Guillem
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

7.  Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

Authors:  H M Collins; T M Morris; S A Watson
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

8.  Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death.

Authors:  Miho Akimoto; Mari Iizuka; Rie Kanematsu; Masato Yoshida; Keizo Takenaga
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

9.  A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.

Authors:  Anita Annaházi; Szabolcs Ábrahám; Klaudia Farkas; András Rosztóczy; Orsolya Inczefi; Imre Földesi; Mónika Szűcs; Mariann Rutka; Vassilia Theodorou; Helene Eutamene; Lionel Bueno; György Lázár; Tibor Wittmann; Tamás Molnár; Richárd Róka
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

10.  Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA.

Authors:  Peerada Yingyuad; Mathieu Mével; Carla Prata; Christos Kontogiorgis; Maya Thanou; Andrew D Miller
Journal:  J RNAi Gene Silencing       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.